On Air Now

Listen

Listen Live Now » 100.3 FM Green Bay, WI

Weather

Current Conditions(Green Bay,WI 54303)

More Weather »
60° Feels Like: 60°
Wind: WSW 6 mph Past 24 hrs - Precip: 0”
Current Radar for Zip

Tonight

Clear 56°

Tomorrow

Isolated Thunderstorms 77°

Wed Night

Clear 56°

Alerts

AstraZeneca heart drug wins approval in China

LONDON (Reuters) - AstraZeneca has won approval for its new heart drug Brilinta in China, an increasingly important market for the British pharmaceuticals group.

China's State Food and Drug Administration has issued an drug import license for the product, meaning it will now be available for treating patients with acute coronary syndrome in the country, the company said on Thursday.

Brilinta has proved better than the cheaper generic medicine clopidogrel in preventing the recurrence of heart attacks, but its sales to date in markets around the world have been disappointing.

Revitalizing the product is an early priority for new Chief Executive Pascal Soriot, who said last month that Brilinta could do "far better".

(Reporting by Ben Hirschler; Editing by Helen Massy-Beresford)

Comments